sprite-preloader
Donnerstag, 24.04.2014 Börsentäglich über 12.000 News von 475 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 884113 ISIN: US1011371077 Ticker-Symbol: BSX 
Aktie:
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
BOSTON SCIENTIFIC CORPORATION Chart 1 Jahr
1-Woche-Intraday-Chart
BOSTON SCIENTIFIC CORPORATION 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
9,94
9,96
20:43
9,921
9,977
20:43

Aktuelle News zu BOSTON SCIENTIFIC Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
BOSTON SCIENTIFIC Aktie jetzt ab 5 Dollar handeln!

--> Artikel lesen
14:36Equities to Watch in the Health Care Sector -- Research on Boston Scientific, Abbott Laboratories, Medtronic, and Insulet3
LONDON, April 24, 2014 /PRNewswire/ -- The trading session on Wednesday, April 23, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,501.65, down 0.08% and the NASDAQ...
--> Artikel lesen
14:03Favorable Legal Outcomes, Events Schedules, New Product Launches, Regulatory Clearances, and Stock Price Updates - Analyst Notes on Mylan, Boston Scientific, Zimmer Holdings, Covidien and Zoetis3
NEW YORK, April 24, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Mylan, Inc. (NASDAQ: MYL), Boston Scientific Corporation (NYSE: BSX), Zimmer Holdings, Inc....
--> Artikel lesen
01:353 Things You Need to Watch For in Boston Scientific's Earnings-

--> Artikel lesen
DiBoston Scientific Receives FDA Approval For Its Latest CRM Devices-

--> Artikel lesen
DiBoston Scientific Begins Clinical Trial of ACUITY X4 LV Pacing Leads and RELIANCE 4-FRONT ICD Leads-

--> Artikel lesen
DiBoston Scientific Begins Clinical Trial of ACUITY' X4 LV Pacing Leads and RELIANCE' 4-FRONT ICD Leads3
NATICK, Mass., April 22, 2014 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX)has conducted the first implant in the clinical trial of the next generation ACUITY' X4 left-ventricular...
--> Artikel lesen
DiNew Data from Studies, Enrollment in Registry, Upcoming Conferences, and Stock Price Movement - Analyst Notes on Alexion, Boston Scientific, Thermo Fisher Scientific, Valeant, and Jazz Pharmaceuticals3
NEW YORK, April 22, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Boston Scientific Corporation (NYSE:BSX), Thermo...
--> Artikel lesen
17.04.Boston Scientific To Host And Webcast Investor Event1
NATICK, Mass., April 17, 2014 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) will host an investor event on May 8, 2014 to provide an update on company Cardiac Rhythm Management and Electrophysiology...
--> Artikel lesen
17.04.Injunction Lifted on Boston Scientific's Guidezilla - Analyst Blog1

--> Artikel lesen
17.04.Injunction Lifted on Boston Scientific's Guidezilla-

--> Artikel lesen
16.04.FDA Clears Boston Scientific's Heart Devices1

--> Artikel lesen
15.04.U.S. FDA OKs new generation Boston Scientific heart pacing devices-

--> Artikel lesen
15.04.Boston Scientific Gets FDA Approval For Defibrillators, Heart Failure Devices7
WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) said it has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care.The...
--> Artikel lesen
15.04.UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib., Heart Failure Devices1

--> Artikel lesen
15.04.Boston Scientific Corp. Reports FDA Approval of Latest Heart Failure Devices, Defibrillators-

--> Artikel lesen
15.04.Boston Scientific Announces FDA Approval Of Innovative New Defibrillators And Heart Failure Devices3
NATICK, Mass., April 15, 2014 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance...
--> Artikel lesen
15.04.UPDATE 1-Injunction lifted on Boston Scientific catheter product-

--> Artikel lesen
15.04.Injunction lifted on Boston Scientific catheter product Guidezilla1

--> Artikel lesen
15.04.BRIEF-U.S. appeals court lifts injunction that had favored Vascular Solutions, concerning Boston Scientific catheter-

--> Artikel lesen
15.04.Boston Scientific PT Raised to $9.00-

--> Artikel lesen
Seite:  Weiter >>
311 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
BOSTON SCIENTIFIC CORPORATION-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
MEDTRONIC42,133-0,48 %Equities to Watch in the Health Care Sector -- Research on Boston Scientific, Abbott Laboratories, Medtronic, and Insulet
LONDON, April 24, 2014 /PRNewswire/ -- The trading session on Wednesday, April 23, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,501.65, down 0.08% and the NASDAQ...
--> Artikel lesen
ST JUDE MEDICAL44,731-1,61 %Earnings Schedule, Financial Results Releases, Buyback Updates, and Acquisitions - Analyst Notes on Express Scripts, Incyte, St. Jude Medical, Novo Nordisk and Stryker
NEW YORK, April 22, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Express Scripts Inc. (NASDAQ: ESRX), Incyte Corporation (NASDAQ: INCY), St. Jude Medical Inc....
--> Artikel lesen
FRESENIUS MEDICAL CARE49,740,00 %dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 22.04.2014: ADIDAS, AIRBUS, ASTRAZENECA, AXEL SPRINGER, BARCLAYS, BASF, BAYER, BB BIOTECH, BRENNTAG, CONTINENTAL, CREDIT SUISSE, DAIMLER, DEUTSCHE BANK, DIAGEO, ...
Ausgewählte Analysten-Einstufungen im dpa-AFX-Nachrichtendienst vom 22.04.2014 ADIDAS NEW YORK - Die US-Bank JPMorgan hat die Einstufung für Adidas vor Zahlen auf "Overweight" mit einem Kursziel...
--> Artikel lesen
RHOEN-KLINIKUM23,57+0,15 %Laufende Fusionskontrollverfahren: Asklepios Kliniken GmbH, Hamburg, Aktienerwerb an der Rhön
Datum der Anmeldung:14.04.2014Aktenzeichen:B3-76/14Unternehmen:Asklepios Kliniken GmbH, Hamburg, Aktienerwerb an der RhönProduktmärkte:KrankenhäuserBundesländer/Unternehmenssitz:Bayern, Hamburg
--> Artikel lesen
ECKERT & ZIEGLER24,975+1,38 %DGAP-HV: Eckert & Ziegler Strahlen- und -3-
DJ DGAP-HV: Eckert & Ziegler Strahlen- und Medizintechnik AG: Bekanntmachung der Einberufung zur Hauptversammlung am 22.05.2014 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG ...
--> Artikel lesen
Lade...